Correlation Between Dermata Therapeutics and Celularity
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Celularity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Celularity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics Warrant and Celularity, you can compare the effects of market volatilities on Dermata Therapeutics and Celularity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Celularity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Celularity.
Diversification Opportunities for Dermata Therapeutics and Celularity
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dermata and Celularity is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics Warrant and Celularity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celularity and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics Warrant are associated (or correlated) with Celularity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celularity has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Celularity go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and Celularity
Assuming the 90 days horizon Dermata Therapeutics Warrant is expected to generate 1.33 times more return on investment than Celularity. However, Dermata Therapeutics is 1.33 times more volatile than Celularity. It trades about 0.15 of its potential returns per unit of risk. Celularity is currently generating about 0.11 per unit of risk. If you would invest 6.35 in Dermata Therapeutics Warrant on November 2, 2024 and sell it today you would lose (3.38) from holding Dermata Therapeutics Warrant or give up 53.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 68.89% |
| Values | Daily Returns |
Dermata Therapeutics Warrant vs. Celularity
Performance |
| Timeline |
| Dermata Therapeutics |
| Celularity |
Dermata Therapeutics and Celularity Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and Celularity
The main advantage of trading using opposite Dermata Therapeutics and Celularity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Celularity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celularity will offset losses from the drop in Celularity's long position.The idea behind Dermata Therapeutics Warrant and Celularity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |